COMMENT: The astronomical rise in weight-loss drug prices caused by Trump’s tariffs could have a significant – and dangerous ...

Eli Lilly and Company (NYSE:LLY) is one of the best growth stocks to buy according to analysts. On August 14, Eli Lilly and ...

Eli Lilly's Mounjaro and Zepbound drove Q2 2025 revenue up 38% and EPS up 92% YoY. Read why LLY stock's recent 20% pullback ...

New diabetes and obesity drugs, like Mounjaro and Ozempic, are changing people's relationships with food. While these drugs ...

Steroid dealers using social media and beauty salons to sell cheap Chinese copies of weight-loss drugs, experts warn ...

Only one of these growth stocks is up big so far in 2025. But all three could be huge winners over the next few years.

Consumers who pay privately for the Mounjaro weight loss drug could have to shell out thousands more if they want to continue with the treatment, after manufacturer Eli Lilly announced an increase to ...

AstraZeneca chief is irked by cost of doing business as Eli Lilly raises price of Mounjaro after presidential pressure ...

European countries spent more than other regions on essential medicines in 2022, at approximately €167 per capita.View on ...